Hello all, just thought I would share this with the investors and anyone else that is wondering how big the application for Gx-C3 might be. While we are now focused on Ovarian Cancer, we have interests in other cancers as well, including breast cancer and thyroid as well as 30 other types that are upregulated with STAT3 (which causes metastasis among other problems for the patient). Please pass around and we need more investors! Our offering officially closes on January 21, 2019 so please pitch in and help us!!! We would greatly appreciate the help in raising funds! IVDRoverview.pdf
Wefunder supports three different federal laws that allow startups to raise money legally. To comply with the law, Wefunder Advisors LLC and Wefunder Portal LLC (both owned by Wefunder Inc) also list startups depending on the regulation used.
Legal May 16th 2016
Wefunder Portal LLC
for 271 startups
Wefunder Advisors LLC
for 101 startups
for 3 startups
Curious how well the companies have done? Or how many raised follow-on financing?
Some fine print: 1) These numbers include startups currently live on Wefunder if they pass their minimum target. 2) Some startups use two different laws at the same time (i.e., Regulation D and Regulation Crowdfunding).
Join 471,182 investors who funded 358 startups with over $127.5 million1
wefunder.com/updates/98364-a-report-on-the-patient-testing-market is managed by
Wefunder Portal LLC.
Wefunder Inc. runs wefunder.com and is the parent company of Wefunder Advisors LLC and Wefunder Portal LLC. Wefunder Advisors is an exempt reporting adviser that advises SPVs used in Reg D offerings. Wefunder Portal is a funding portal (CRD #283503) that operates sections of wefunder.com where some Regulation Crowdfunding offerings are made.
Wefunder, Inc. operates sections of wefunder.com where some Regulation D and A offerings are made. Wefunder, Inc. is not regulated as either a broker-dealer or funding portal and is not a member of FINRA.
You may also view our Privacy Notice.